CITADEL PRECISION MEDICINE LLC is a leading provider of cutting-edge data-driven, Precision Medicine technologies and services. Founded by a team of investors, entrepreneurs and industry thought-leaders, we offer innovative analytical products and services in the field of Precision Medicine Design and Analytics. The goal of CPM is to provision appropriate patients globally with the right medicine, at the right time and at the right dose, to help address issues of adverse events and treatment responsiveness in conditions such as cancer, cardiovascular and rare and chronic disorders.
We strive to empower patients globally with available treatment options to enable better responsiveness and ensure safe and targeted therapies.
We are passionate about creating ‘Health Equity’ for patients globally, kindled by deep scientific curiosity and the integrity of thought and action towards the compliant use of data.
We seek to be leaders in the field of Precision Medicine & Healthcare Strategies through our deep domain expertise, advanced AI/ML technologies and consulting capabilities.
CITADEL PRECISION MEDICINE is inspired by the acute need to provide tailored therapies and connected health strategies, for patients suffering from cancer, rare diseases and other chronic disorders. CPM’s Digital’s HIPAA compliant ‘Accuitive’ solution, is a suite of technology products and services to help users create value-driven, patient-centric Pharmacogenomic therapeutic regimens.
At CPM the process we follow based on use case studies in each disciplinary
Precision medicine analytics have the ability to detect the early onset and subsequent progression of disease, positively impacting the market potential of pharmaceutical products for chronic, and rare diseases and genetic disorders.
Precision medicine is beginning to make an impact on the treatment of different diseases, but there are still challenges that must be overcome, such as the complexity of interventions, the need for marker validation, and the level of evidence necessary to demonstrate effectiveness.
In an effort to address these challenges, Citadel Precision Medicine (CPM)’s initiatives are constructed on a foundation of Science, Discovery and Real-World Healthcare experiences. CPM’s 3 cornerstones, viz; Global Health Networks, Global Insights and Global Health Equity, are oriented towards leveraging seminal insights from patient and healthcare journeys, medical expertise and foundational semantic knowledgebases, to transform the treatment recommendations and healthcare delivery to patients in need.
Citadel Precision Medicine (CPM) aims to create and foster Global Health Networks & Partnerships with Hospitals, Diagnostic Labs, Genetic Testing Labs, Payer networks, Patient Networks, to provision insights and decision support systems.
CPM’s ‘ACCUITIVE’ Technology Suite facilitates faster time from interoperable data to accurate insights and precision end outcomes.
Citadel Precision Medicine (CPM) aims to create and foster Global Health Networks & Partnerships with Hospitals, Diagnostic Labs, Genetic Testing Labs, Payer networks, Patient Networks, to provision insights and decision support systems.
